RECRUITING

Feasibility of Implementing Time-restricted Eating in Women With Mild Cognitive Impairment

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This study will investigate the feasibility of implementing a time-restricted eating intervention in females with mild cognitive impairment. Targeted therapeutic interventions that improve cognitive impairment and delay onset of ADRD are particularly important for females, who have twice the lifetime risk of developing AD, compared to males.

Official Title

Feasibility of Implementing Time-restricted Eating in Women With Mild Cognitive Impairment

Quick Facts

Study Start:2024-04-01
Study Completion:2024-12
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05858008

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:45 Years to 95 Years
Sexes Eligible for Study:FEMALE
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Postmenopausal Women
  2. * Age 45-95
  3. * Diagnosis of mild cognitive impairment
  1. * Individuals prone to hypoglycemia
  2. * Liver disease
  3. * Taking medications that affect eating behaviors
  4. * Alcohol consumption of \>2 drinks per day
  5. * Significant circadian disruption
  6. * Having care-taking responsibilities that significantly affect sleep
  7. * Shift work or irregular lifestyle
  8. * Diagnosed clinical eating disorder
  9. * Participating in a formal weight loss program

Contacts and Locations

Study Contact

Matt Thomas, PhD
CONTACT
(859) 218-6770
jmthomg@uky.edu
Julie S Pendergast, PhD
CONTACT
(859) 218-6770
julie.pendergast@uky.edu

Principal Investigator

Julie Pendergast, PhD
PRINCIPAL_INVESTIGATOR
University of Kentucky

Study Locations (Sites)

University of Kentucky
Lexington, Kentucky, 40536
United States

Collaborators and Investigators

Sponsor: Julie Pendergast

  • Julie Pendergast, PhD, PRINCIPAL_INVESTIGATOR, University of Kentucky

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-04-01
Study Completion Date2024-12

Study Record Updates

Study Start Date2024-04-01
Study Completion Date2024-12

Terms related to this study

Additional Relevant MeSH Terms

  • Mild Cognitive Impairment